Unknown PHASE3 INTERVENTIONAL 4-arm NCT01619046

Safety, Efficacy and Pharmacokinetics of GreenGene™ F to Previously Treated Patients With Severe Hemophilia A

Determination of Safety, Efficacy and Pharmacokinetics of GreenGene™ F in Previously Treated Patients 12 Years of Age or Older Diagnosed With Severe Hemophilia A

Sponsor: Atlantic Research Group

Conditions Hemophilia A

Interventions GreenGene™ F GreenGene™ F and an approved recombinant Factor VIII product

Updated 8 times since 2017 Last updated: Jul 2, 2014 Started: Mar 31, 2013 Primary completion: Jul 31, 2015 Completion: Sep 30, 2015

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE3 trial investigates Hemophilia A and is currently ongoing. Atlantic Research Group leads this study, which shows 8 recorded versions since 2013 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

8 versions recorded

Sep 2025 — Present [monthly]

Unknown PHASE3
Sep 2024 — Sep 2025 [monthly]

Unknown PHASE3
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE3

Status: Unknown Status → Unknown
Jul 2022 — Jul 2024 [monthly]

Unknown Status PHASE3
Jan 2021 — Jul 2022 [monthly]

Unknown Status PHASE3

▶ Show 3 earlier versions

Jun 2018 — Jan 2021 [monthly]

Unknown Status PHASE3
Feb 2017 — Jun 2018 [monthly]

Unknown Status PHASE3
Jan 2017 — Feb 2017 [monthly]

Unknown Status PHASE3

First recorded

Mar 2013

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Atlantic Research Group
Green Cross Corporation

Data source: GC Biopharma Corp

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Barnaul, Russia , Basingstoke, United Kingdom , Boise, United States , Chicago, United States , Christchurch, New Zealand , City of Westminster, United Kingdom , Dnipro, Ukraine , Donetsk, Ukraine , East Lansing, United States , Edmonton, Canada and 24 more locations